2021
DOI: 10.1016/j.procbio.2021.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic-fluorescent nanoliposomes decorated with folic acid for active delivery of cisplatin and gemcitabine to cancer cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 54 publications
0
2
0
Order By: Relevance
“…[21,22,23] Moreover, in active tumor targeting, conjugating folic acid and anti-FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor-mediated endocytosis. [24,25] In this strategy, the cellular uptake of nanocarriers can increase by ten-fold compared with non-targeted drug delivery systems and administration of pure chemotherapeutics. [26] In this study, we applied functionalized fluorescent GQDs as a new selective drug delivery system for targeting of tamoxifen anticancer agent to folate and estrogen receptor positive breast cancer cells with simultaneously applicable in detect, tracing and treatment.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…[21,22,23] Moreover, in active tumor targeting, conjugating folic acid and anti-FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor-mediated endocytosis. [24,25] In this strategy, the cellular uptake of nanocarriers can increase by ten-fold compared with non-targeted drug delivery systems and administration of pure chemotherapeutics. [26] In this study, we applied functionalized fluorescent GQDs as a new selective drug delivery system for targeting of tamoxifen anticancer agent to folate and estrogen receptor positive breast cancer cells with simultaneously applicable in detect, tracing and treatment.…”
Section: Introductionmentioning
confidence: 99%
“…PEGylation of nanoparticles can not only facilitate the passive targeting of cancer cells but also increase their hydrophilicity, avoid the immune system response, and increase the circulation time of nano‐complex in body serum [21,22,23] . Moreover, in active tumor targeting, conjugating folic acid and anti‐FR antibodies with nanocarriers can considerably raise the internalization efficiency of nanocarriers by cancer cells via folate receptor‐mediated endocytosis [24,25] . In this strategy, the cellular uptake of nanocarriers can increase by ten‐fold compared with non‐targeted drug delivery systems and administration of pure chemotherapeutics [26] …”
Section: Introductionmentioning
confidence: 99%